Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 07/31 04:00:00 pm
146.27 USD   +1.18%
07/27 BioMarin Joins the NASDAQ-100 Index
07/20 BioMarin Provides Program Update for Talazoparib in Metastatic Br..
07/15 BIOMARIN TO HOS : 30pm ET
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
144.32(c) 145.94(c) 144.32(c) 144.56(c) 146.27(c) Last
1 399 521 1 228 633 1 005 601 951 365 1 110 210 Volume
-0.46% +1.12% -1.11% +0.17% +1.18% Change
More quotes
Financials ($)
Sales 2015 882 M
EBIT 2015 -310 M
Net income 2015 -341 M
Finance 2015 82,6 M
Yield 2015 -
Sales 2016 1 105 M
EBIT 2016 -193 M
Net income 2016 -260 M
Debt 2016 255 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 26,5x
EV / Sales 2016 21,5x
Capitalization 23 452 M
More Financials
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
08/03Earnings Release
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
07/28 BIOMARIN PHARMACEUTICAL : Joins the NASDAQ-100 Index
07/27 BioMarin Joins the NASDAQ-100 Index
07/21 BIOMARIN PHARMACEUTICAL : Provides Program Update for Talazoparib in Metastatic ..
07/21 BIOMARIN PHARMACEUTICAL : Provides Program Update for Talazoparib in Metastatic ..
07/21 BIOMARIN PHARMACEUTICAL : Provides Program Update for Talazoparib in Metastatic ..
07/20 BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
07/16 BIOMARIN PHARMACEUTICAL : to Host Second Quarter 2015 Financial Results Conferen..
07/15 BIOMARIN PHARMACEUTICAL : Investigators from BioMarin Pharmaceutical Target Gene..
More news
Sector news : Generic Pharmaceuticals
07/31 HOSPIRA : Citing vulnerability to hacking, FDA says hospitals should stop using ..
07/31 HOSPIRA : Citing hacking risk, FDA says Hospira pump shouldn't be used
07/31DJWHO Says Ebola Vaccine Effective in African Trial -- Update
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
07/27 FibroGen to proceed with mid-stage study of FG-3019 in DMD
07/23 PREMARKET BIOTECH DIGEST : The M&A Frenzy, Anavex's Phase 2a Data, Big Day For E..
07/22 Catalyst Pharma starts rolling NDA submission for Firdapse in LEMS
07/07 The Race To Cure Duchenne Muscular Dystrophy - An Investor's Guide
07/06 Catabasis Pharma's CAT-1004 Fast Track'd for DMD


Comments 
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends BIOMARIN PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions